{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,18]],"date-time":"2026-01-18T11:41:02Z","timestamp":1768736462448,"version":"3.49.0"},"reference-count":36,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2002,6,1]],"date-time":"2002-06-01T00:00:00Z","timestamp":1022889600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2002,6,1]],"date-time":"2002-06-01T00:00:00Z","timestamp":1022889600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["jpet.aspetjournals.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Journal of Pharmacology and Experimental Therapeutics"],"published-print":{"date-parts":[[2002,6]]},"DOI":"10.1124\/jpet.301.3.1079","type":"journal-article","created":{"date-parts":[[2003,1,10]],"date-time":"2003-01-10T18:37:30Z","timestamp":1042223850000},"page":"1079-1087","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":50,"title":["Cationic Drug Pharmacokinetics in Diseased Livers Determined by Fibrosis Index, Hepatic Protein Content, Microsomal Activity, and Nature of Drug"],"prefix":"10.1016","volume":"301","author":[{"given":"Daniel Y.","family":"Hung","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ping","family":"Chang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kee","family":"Cheung","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Brett","family":"McWhinney","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Paul P.","family":"Masci","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael","family":"Weiss","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael S.","family":"Roberts","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1124\/jpet.301.3.1079_bib1","doi-asserted-by":"crossref","first-page":"912","DOI":"10.1139\/y00-066","article-title":"Differential alteration of cytochrome P450 isoenzymes in two experimental models of cirrhosis.","volume":"78","author":"Bastien","year":"2000","journal-title":"Can J Physiol Pharmacol"},{"key":"10.1124\/jpet.301.3.1079_bib2","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1007\/BF01049676","article-title":"Glycosylation of \u03b11-acid glycoprotein in septic shock: changes in degree of branching and in expression of sialyl Lewis-x groups.","volume":"13","author":"Brinkman-van der Linden","year":"1996","journal-title":"Glycoconjugate J"},{"key":"10.1124\/jpet.301.3.1079_bib3","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1002\/hep.1840180110","article-title":"Hepatic enzyme activity is the major factor determining elimination rate of high-clearance drugs in cirrhosis.","volume":"18","author":"Callaghan","year":"1993","journal-title":"Hepatology"},{"key":"10.1124\/jpet.301.3.1079_bib4","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1006\/jsre.1996.0376","article-title":"An optimised model for rat liver perfusion studies.","volume":"66","author":"Cheung","year":"1996","journal-title":"J Surg Res"},{"key":"10.1124\/jpet.301.3.1079_bib5","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1016\/S0168-8278(05)80500-8","article-title":"Increased hepatic lysosomal activity in biliary cirrhosis originates from hepatocytes rather than from macrophages.","volume":"20","author":"Dufour","year":"1994","journal-title":"J Hepatol"},{"key":"10.1124\/jpet.301.3.1079_bib6","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1016\/0016-5085(94)90173-2","article-title":"Hepatocellular Na+\/H+ exchange is activated at transcriptional and posttranscriptional levels in rat biliary cirrhosis.","volume":"107","author":"Elsing","year":"1994","journal-title":"Gastroenterology"},{"key":"10.1124\/jpet.301.3.1079_bib7","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1002\/hep.1840170222","article-title":"Clearance by the liver in cirrhosis. I. Relationship between propranolol metabolism in vitro and its extraction by the perfused liver in the rat.","volume":"17","author":"Fenyves","year":"1993","journal-title":"Hepatology"},{"key":"10.1124\/jpet.301.3.1079_bib8","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1002\/hep.1840180412","article-title":"Clearance by the liver in cirrhosis. II. Characterization of propranolol uptake with the multiple-indicator dilution technique.","volume":"18","author":"Gariepy","year":"1993","journal-title":"Hepatology"},{"key":"10.1124\/jpet.301.3.1079_bib9","doi-asserted-by":"crossref","first-page":"G775","DOI":"10.1152\/ajpgi.2000.278.5.G775","article-title":"Uptake of lactate by the liver: effect of red blood cell carriage.","volume":"278","author":"Goresky","year":"2000","journal-title":"Am J Physiol Gastrointest Liver Physiol"},{"key":"10.1124\/jpet.301.3.1079_bib10","doi-asserted-by":"crossref","first-page":"833","DOI":"10.1023\/A:1007508325512","article-title":"Functional impairment of sinusoidal membrane transport of organic cations in rats with CCl4-induced hepatic failure.","volume":"17","author":"Hong","year":"2000","journal-title":"Pharm Res"},{"key":"10.1124\/jpet.301.3.1079_bib11","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/S0300-5089(21)00642-8","article-title":"Hepatic circulation in cirrhosis.","volume":"14","author":"Huet","year":"1985","journal-title":"Clin Gastroenterol"},{"key":"10.1124\/jpet.301.3.1079_bib12","doi-asserted-by":"crossref","first-page":"780","DOI":"10.1016\/S0022-3565(24)29597-5","article-title":"Structure-hepatic disposition relationships for cationic drugs in isolated perfused rat livers: transmembrane exchange and cytoplasmic binding process.","volume":"297","author":"Hung","year":"2001","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1124\/jpet.301.3.1079_bib13","doi-asserted-by":"crossref","first-page":"566","DOI":"10.1023\/A:1018926902083","article-title":"A simple and rapid fluorometric determination method of alpha 1-acid glycoprotein in serum using quinaldine red.","volume":"11","author":"Imamura","year":"1994","journal-title":"Pharm Res"},{"key":"10.1124\/jpet.301.3.1079_bib14","first-page":"G1259","article-title":"CYP2E1 is not involved in early alcohol-induced liver injury.","volume":"277","author":"Kono","year":"1999","journal-title":"Am J Physiol"},{"key":"10.1124\/jpet.301.3.1079_bib15","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1016\/S0168-8278(00)80362-1","article-title":"Relationship between hepatic mitochondrial functions in vivo and in vitro in rats with carbon tetrachloride-induced liver cirrhosis.","volume":"33","author":"Kr\u00e4henb\u00fchl","year":"2000","journal-title":"J Hepatol"},{"key":"10.1124\/jpet.301.3.1079_bib16","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1016\/S0021-9258(19)52451-6","article-title":"Protein measurement with the Folin phenol reagent.","volume":"193","author":"Lowry","year":"1951","journal-title":"J Biol Chem"},{"key":"10.1124\/jpet.301.3.1079_bib17","doi-asserted-by":"crossref","first-page":"1428","DOI":"10.1002\/hep.1840160620","article-title":"Liver regeneration and the effect of exogenous putrescine on regenerative activity after partial hepatectomy in cirrhotic rats.","volume":"16","author":"MacIntosh","year":"1992","journal-title":"Hepatology"},{"key":"10.1124\/jpet.301.3.1079_bib18","doi-asserted-by":"crossref","first-page":"596","DOI":"10.1016\/0003-2697(76)90114-7","article-title":"Quantitative determination of cytochrome P450 in rat liver homogenate.","volume":"75","author":"Matsubara","year":"1976","journal-title":"Anal Biochem"},{"key":"10.1124\/jpet.301.3.1079_bib19","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1046\/j.1365-2125.2000.00193.x","article-title":"Nonspecific binding of drugs to human liver microsomes.","volume":"49","author":"McLure","year":"2000","journal-title":"Br J Clin Pharmacol"},{"key":"10.1124\/jpet.301.3.1079_bib20","doi-asserted-by":"crossref","first-page":"370","DOI":"10.2165\/00003088-199529050-00005","article-title":"Clinical pharmacokinetic and pharmacodynamic considerations in patients with liver disease. An update.","volume":"29","author":"Morgan","year":"1995","journal-title":"Clin Pharmacokinet"},{"key":"10.1124\/jpet.301.3.1079_bib21","first-page":"1359","article-title":"Nonspecific binding to microsomes: impact on scale-up of in vitro intrinsic clearance to hepatic clearance as assessed through examination of warfarin, imipramine, and propranolol.","volume":"25","author":"Obach","year":"1997","journal-title":"Drug Metab Dispos"},{"key":"10.1124\/jpet.301.3.1079_bib22","first-page":"267","article-title":"Sulfation of acetaminophen by the perfused rat liver: the effect of red blood cell carriage.","volume":"22","author":"Pang","year":"1995","journal-title":"Hepatology"},{"key":"10.1124\/jpet.301.3.1079_bib23","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1007\/BF01059688","article-title":"Hepatic clearance of drugs. I. Theoretical considerations of a \u201cwell-stirred\u201d model and a \u201cparallel tube\u201d model. Influence of hepatic blood flow, plasma and blood cell binding, and the hepatocellular enzymatic activity on hepatic drug clearance.","volume":"5","author":"Pang","year":"1977","journal-title":"J Pharmacokinet Biopharm"},{"key":"10.1124\/jpet.301.3.1079_bib24","doi-asserted-by":"crossref","first-page":"1183","DOI":"10.1016\/S0016-5085(82)80126-1","article-title":"High yield micronodular cirrhosis in the rat.","volume":"83","author":"Proctor","year":"1982","journal-title":"Gastroenterology"},{"key":"10.1124\/jpet.301.3.1079_bib25","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1016\/0016-5085(87)90433-1","article-title":"Aminopyrine N-demethylation by rats with liver cirrhosis. Evidence for the intact cell hypothesis. A morphometric-functional study.","volume":"93","author":"Reichen","year":"1987","journal-title":"Gastroenterology"},{"key":"10.1124\/jpet.301.3.1079_bib26","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1023\/A:1020992421184","article-title":"Modeling of hepatic elimination and organ distribution kinetics with the extended convection-dispersion model.","volume":"27","author":"Roberts","year":"1999","journal-title":"J Pharmacokinet Biopharm"},{"key":"10.1124\/jpet.301.3.1079_bib27","doi-asserted-by":"crossref","first-page":"1579","DOI":"10.1002\/1520-6017(200012)89:12<1579::AID-JPS8>3.0.CO;2-Y","article-title":"Commentary: using the convection-dispersion model and transit time density functions in the analysis of organ distribution kinetics.","volume":"89","author":"Roberts","year":"2000","journal-title":"J Pharm Sci"},{"key":"10.1124\/jpet.301.3.1079_bib28","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1007\/BF01106706","article-title":"A dispersion model of hepatic elimination: 1. formulation of the model and bolus considerations.","volume":"14","author":"Roberts","year":"1986","journal-title":"J Pharmacokinet Biopharm"},{"key":"10.1124\/jpet.301.3.1079_bib29","doi-asserted-by":"crossref","first-page":"399","DOI":"10.2165\/00003088-199937050-00004","article-title":"Effects of liver disease on pharmacokinetics.","volume":"37","author":"Rodighiero","year":"1999","journal-title":"Clin Pharmacokinet"},{"key":"10.1124\/jpet.301.3.1079_bib30","series-title":"Clinical Pharmacokinetics","first-page":"137","author":"Rowland","year":"1995"},{"key":"10.1124\/jpet.301.3.1079_bib31","series-title":"Diseases of the Liver and Biliary System","year":"1993"},{"key":"10.1124\/jpet.301.3.1079_bib32","doi-asserted-by":"crossref","first-page":"335A","DOI":"10.1111\/j.1530-0277.1996.tb01803.x","article-title":"Role of Kupffer cell-derived reactive oxygen intermediates in alcoholic liver disease in rats in vivo.","volume":"20","author":"Takeyama","year":"1996","journal-title":"Alcohol Clin Exp Res"},{"key":"10.1124\/jpet.301.3.1079_bib33","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1016\/S0168-8278(98)80068-8","article-title":"Kinetic analysis of vascular marker distribution in perfused rat livers after regeneration following partial hepatectomy.","volume":"29","author":"Weiss","year":"1998","journal-title":"J Hepatol"},{"key":"10.1124\/jpet.301.3.1079_bib34","doi-asserted-by":"crossref","first-page":"1331","DOI":"10.1038\/sj.bjp.0703448","article-title":"Cytoplasmic binding and disposition kinetics of diclofenac in the isolated perfused rat liver.","volume":"130","author":"Weiss","year":"2000","journal-title":"Br J Pharmacol"},{"key":"10.1124\/jpet.301.3.1079_bib35","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1007\/BF02459999","article-title":"On the validity of the dispersion model of hepatic drug elimination when intravascular transit time densities are long-tailed.","volume":"59","author":"Weiss","year":"1997","journal-title":"Bull Math Biol"},{"key":"10.1124\/jpet.301.3.1079_bib36","doi-asserted-by":"crossref","first-page":"1904","DOI":"10.1172\/JCI112186","article-title":"Hepatic microcirculation in the perfused cirrhotic rat liver.","volume":"76","author":"Varin","year":"1985","journal-title":"J Clin Invest"}],"container-title":["The Journal of Pharmacology and Experimental Therapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022356524357106?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022356524357106?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1124\/jpet.301.3.1079","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,19]],"date-time":"2025-02-19T23:21:06Z","timestamp":1740007266000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0022356524357106"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2002,6]]},"references-count":36,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2002,6]]}},"alternative-id":["S0022356524357106"],"URL":"https:\/\/doi.org\/10.1124\/jpet.301.3.1079","relation":{},"ISSN":["0022-3565"],"issn-type":[{"value":"0022-3565","type":"print"}],"subject":[],"published":{"date-parts":[[2002,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Cationic Drug Pharmacokinetics in Diseased Livers Determined by Fibrosis Index, Hepatic Protein Content, Microsomal Activity, and Nature of Drug","name":"articletitle","label":"Article Title"},{"value":"The Journal of Pharmacology and Experimental Therapeutics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1124\/jpet.301.3.1079","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2002 The American Society for Pharmacology and Experimental Therapeutics","name":"copyright","label":"Copyright"}]}}